Developer docs
API playgroundTry for free, no card

Search company profiles

CooperSurgical

Full company profile

uuid0003i9h

Namestring
CooperSurgical
Legal namestring
CooperSurgical, Inc.
Company typeenum
Private
Founded yearint
1990
Descriptiontext

CooperSurgical, Inc. is a wholly-owned subsidiary of CooperCompanies (Nasdaq: COO) that manufactures and distributes medical devices and consumables for women's health, fertility, and gynecological surgery. Founded in 1990 and headquartered in Trumbull, Connecticut, the company offers more than 600 clinically relevant products organized across reproductive care (Paragard copper IUD, fertility preservation), fertility and birth (ART equipment, media and consumables, donor egg/sperm services, labor and delivery devices), and women's care (office diagnostics, pessaries, gynecological surgical instruments). Operating brands include Paragard, Wallace (catheters used in the first successful IVF), California Cryobank (#1 US sperm bank), Donor Egg Bank USA, Cord Blood Registry, ORIGIO, LifeGlobal, SAGE, K-Systems, RI Witness, ZyMōt, RUMI II, Lone Star, and Fetal Pillow.

The company sells through a global direct sales force serving fertility clinics, hospitals, labor and delivery units, OB/GYN practices, and ambulatory surgery centers, with products registered in over 130 countries and manufacturing operations in the United States, Costa Rica, and Europe. The technology base spans patented IVF laboratory equipment (RI Witness electronic witnessing, K-Systems workstations and incubators, ZyMōt sperm separation), branded ART culture media (LifeGlobal one-step, ORIGIO sequential, SAGE vitrification), labor and delivery disposables (Fetal Pillow, Bakri balloon, DuoRipe, MityOne), and gynecologic surgical instruments (RUMI II uterine manipulator, Lone Star retractor, Advincula Delineator). Pricing is negotiated B2B under multi-year contracts; the company does not publish list prices.

Revenue is generated across four streams: medical device and equipment sales, ART media and consumables, fertility and cryopreservation services (IVF shipping via Core Cryolab, cryo-storage billing via Embryo Options, genetic testing), and donor egg/sperm banking. Growth has been driven by a sustained acquisition program (obp Medical 2021, Cook Medical Reproductive Health 2022, ZyMōt 2024, obp Surgical 2024 at $100M, reproductive supplement distribution 2025) and incremental product launches including an AI-integrated PGT analysis system and the ViaBL warming kit. The parent reported 8% year-over-year revenue growth for the CooperSurgical business unit in Q2 2026. The company also faces ongoing product liability exposure, notably the Paragard multidistrict litigation (over 3,500 cases alleging breakage during removal) and IVF culture media litigation tied to a December 2023 Class 2 recall.

Short descriptiontext

CooperSurgical, a CooperCompanies subsidiary, provides 600+ medical devices and services spanning fertility treatments, ART consumables, labor and delivery, gynecological surgery, and women's health diagnostics to hospitals, fertility clinics, and OB/GYN practices in 130+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersTrumbull, United States
HQ citystring
Trumbull
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices29 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
fertility medical devices, women's health products, assisted reproductive technology, IVF laboratory equipment, gynecological surgical instruments
Industry3 codes
1Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits)
CodeHLAHADAMPrimaryYes
2Cell & Tissue Banking (biobanking, cord blood/tissue)
CodeHLAAAGAEPrimaryNo
3Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests)
CodeCRADAMAHPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers423450
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Women's Health and Fertility Medical Devices
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of medical devices, equipment, and surgical instruments to healthcare providers including fertility clinics, hospitals, and OB/GYN practices. Products include ART equipment, surgical instruments, diagnostic devices, and fertility consumables.

coopersurgical.com
2ART Media and Consumables
TypeOne Time License
Description

Sale of assisted reproductive technology media, culture solutions, and consumables for IVF laboratories including dishes, pipettes, needles, catheters, and vitrification products.

coopersurgical.com
3Services
TypeProfessional Services
Description

Services including IVF shipping (Core Cryolab), cryo-storage billing (Embryo Options), fertility preservation, and genetic testing services.

coopersurgical.com
4Donor Egg and Sperm
TypeOne Time License
Description

Sale of donor sperm and eggs through California Cryobank and Donor Egg Bank USA, including newborn stem cell banking through Cord Blood Registry.

coopersurgical.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1No public tiered pricing available
ModelOtherBilling cadenceMulti-year contract
Notes

CooperSurgical operates through healthcare provider channels with quote-based pricing for medical devices and equipment. No public pricing listed on website.

coopersurgical.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 24 records shown
1Paragard
Description

Intrauterine copper contraceptive for pregnancy prevention for up to 10 years

coopersurgical.com
+23 more records
Core offering1 text field

CooperSurgical manufactures and sells a portfolio of over 600 clinically relevant medical devices and consumables for women's healthcare providers, spanning contraception (Paragard IUD), assisted reproductive technology (IVF equipment, media, consumables), labor and delivery products, gynecological surgical instruments, and women's health diagnostics. The company also provides related services including IVF shipping, cryo-storage billing, donor egg and sperm banking, and newborn stem cell preservation through sub-brands such as California Cryobank, Donor Egg Bank USA, and Cord Blood Registry.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 8% year-over-year revenue growth in CooperSurgical business unit (Q2 2026)
+2 more records
Product overview1 text field

CooperSurgical offers a comprehensive portfolio of over 600 clinically relevant medical devices for women's healthcare providers, encompassing fertility and birth solutions, reproductive care, and women's health. The product portfolio operates as a multi-brand platform organized across three main categories: Reproductive Care (Paragard copper IUD, fertility preservation), Fertility & Birth (ART equipment, media, consumables, genetic testing, donor services, labor & delivery), and Women's & Family Care (surgical instruments, diagnostics, pessaries). Key brands include LifeGlobal, ORIGIO, and SAGE for embryo culture media; K-Systems for IVF workstations; Wallace and RI Witness for ART procedures; California Cryobank and Cord Blood Registry for family banking; plus surgical brands like RUMI II, Lone Star, and ALLY II UPS for gynecological surgery. The portfolio spans from contraception to fertility treatments, labor and delivery, and surgical interventions.

Product and service36 records
1Paragard Copper IUD
CategoryContraception
Description

Copper-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 10 years. Provides proven >99% efficacy, 100% hormone-free contraception that is immediately reversible. Sold to healthcare providers including OB/GYN practices.

2ZyMōt Multi Sperm Separation Device
CategoryAssisted Reproductive Technology
Description

Sperm separation device using a patented approach to separate motile sperm from non-motile sperm in a semen sample. Motile sperm separated by the device are more likely to help patients achieve a successful pregnancy. Sold to fertility clinics and ART laboratories.

3California Cryobank
CategoryDonor Gamete Services
Description

The #1 sperm bank in the U.S. offering one of the world's largest and most diverse donor catalogs with rigorous donor screening requirements, financing, and storage options. Provides donor sperm for fertility clinics and patients.

4Donor Egg Bank USA
CategoryDonor Gamete Services
Description

Expert in egg vitrification, providing access to donor egg services with comprehensive screening and storage options. Recognized as #1 egg bank in the U.S.

5Cord Blood Registry (CBR)
CategoryNewborn Stem Cell Banking
Description

#1 recommended newborn stem cell preservation company by OB/GYNs, helping families preserve stem cells from cord blood for future medical use.

6Embryo Options
CategoryDigital Services
Description

Digital cryopreservation billing and management platform that automates cryo-storage billing, enables real-time account access, and provides embryo disposition options including donation to research, donation to another family, or thaw and discard.

7Core Cryolab IVF Shipping
CategoryIVF Logistics Services
Description

IVF shipping solutions providing transport of cryopreserved materials for clinics and patients since 2005.

8LifeGlobal Media
CategoryART Media and Consumables
Description

Pioneer and leader in 1-Step media for embryo culture, offering high-quality pharmaceutical-grade mineral oils and HSA for ART applications.

9ORIGIO Sequential Series Media
CategoryART Media and Consumables
Description

Innovative IVF media positioned as one of the leaders in the global IVF Media market, offering sequential series media and micropipettes for embryo culture.

10SAGE Vitrification Solutions
CategoryART Media and Consumables
Description

Vitrification solutions including SAGE 1-Step culture and transfer medium, GM-CSF variants, and ViaBL warming kits.

11K-Systems Workstations and Incubators
CategoryIVF Laboratory Equipment
Description

Range of workstations, incubators, and supporting equipment designed for IVF laboratories.

12Wallace Catheters
CategoryART Consumables
Description

Wallace catheter was used in the first successful IVF treatment and remains the most popular catheter worldwide. Includes oocyte recovery systems, IUI catheters, and embryo transfer catheters.

13RI Witness Electronic Witnessing System
CategoryIVF Laboratory Equipment
Description

Electronic witnessing system that constantly communicates with patient management systems to prevent sample misidentification in IVF laboratories.

14PGT-Complete Genetic Test
CategoryGenetic Testing
Description

Four-in-one genetic test for preimplantation genetic testing, providing clinically comprehensive insights for embryo selection.

15ER-Complete Test
CategoryGenetic Testing
Description

3-in-1 test for optimal endometrium and embryo transfer, identifying the right time and right environment for embryo transfer.

16Endosee Advance System
CategoryWomen's Health Diagnostics
Description

Office hysteroscopy device incorporating benefits of direct visualization without limitations of traditional hysteroscopy for office-based procedures in OB/GYN practices.

17Milex Pessaries
CategoryPelvic Health Products
Description

Pessaries for pelvic organ prolapse and urinary incontinence including ring, Gellhorn, cube, Gehrung, Shaatz pessaries and vaginal dilators.

18RUMI II Uterine Manipulator
CategoryGynecological Surgical Instruments
Description

Uterine manipulation devices with articulating system, locking handle, soft distal tip, silicone balloon, and integrated catheter for chromopertubation for gynecologic laparoscopic procedures.

19Lone Star Self-Retaining Retractor System
CategorySurgical Instruments
Description

Self-retaining retractor system providing incision retraction and aiding visualization during surgical procedures, including disposable elastic stays and rings.

20ALLY II UPS Uterine Positioning System
CategoryGynecological Surgical Instruments
Description

Uterine positioning system designed for minimally invasive gynecological procedures with redesigned stability and improved mobility.

21Advincula Delineator
CategoryGynecological Surgical Instruments
Description

Single-use disposable uterine manipulator designed for TLH, LSH, and LAVH procedures with Koh-Efficient system integrated and rigid colpotomy cup.

22ONETRAC LX Surgical Retractor
CategorySurgical Instruments
Description

Single-use, cordless surgical retractor with integrated multi-LED light source for specialty surgery procedures.

23INSORB Skin Stapler
CategorySurgical Instruments
Description

Absorbable skin stapler providing rapid, cosmesis-proven skin closure solution for C-section and other surgical procedures.

24Doppler Blood Flow Monitor
CategorySurgical Instruments
Description

Provides audible and visual feedback of blood flow during surgical procedures.

25Bakri Postpartum Balloon
CategoryLabor and Delivery Products
Description

Provides temporary control or reduction of postpartum uterine bleeding when conservative management is warranted.

26Fetal Pillow Cephalic Elevation Device
CategoryLabor and Delivery Products
Description

Effective solution for delivering a deeply impacted fetal head during C-section, providing cephalic elevation. FDA 510(k) cleared.

27DuoRipe Cervical Ripening Balloon
CategoryLabor and Delivery Products
Description

Double-balloon catheter for mechanical dilation of cervical canal prior to labor induction at term when cervix is unfavorable.

28MityOne Vacuum-Assisted Delivery Device
CategoryLabor and Delivery Products
Description

One-piece vacuum-assisted delivery device to assist practitioners in delivery of an infant during vacuum-assisted deliveries.

29Guardian Vaginal Retractor
CategorySurgical Instruments
Description

Single-use device designed to achieve improved visualization and access required during vaginal and/or perineal wound repair.

30Carter-Thomason CloseSure System
CategorySurgical Instruments
Description

Single-case use, handheld suture grasping device for port site closure during laparoscopic procedures.

31See Clear Smoke Evacuation System
CategorySurgical Instruments
Description

Passive, disposable, multistage laparoscopic filter system that traps smoke and aerosols during surgical procedures.

32TPC Micropipettes
CategoryART Consumables
Description

Range of ICSI, Holding, Biopsy, and Hatching and Dissection micropipettes for IVF laboratory procedures.

33Quinn's Advantage Sequential Media
CategoryART Media and Consumables
Description

Sequential media system available in Europe, U.S.A., China and Australia for embryo culture.

34OB/Mobius Cesarean Section Retractor
CategoryLabor and Delivery Products
Description

Elastic retractor providing 360° of circumferential retraction while lining the wound to protect against contamination during C-section.

35Belly Bands Abdominal Fetal Monitoring Belt
CategoryLabor and Delivery Products
Description

Abdominal fetal monitoring belt used to hold transducers in place during fetal monitoring.

36ViaBL Super-Fast Blastocyst Warming Kit
CategoryART Media and Consumables
Description

Super-fast blastocyst warming kit launched in March 2025 for IVF procedures, available for sale in select countries worldwide.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-04
Description

CooperSurgical launched sustainART pilot program in Melbourne, Australia with Adora Fertility as the first participating clinic. The program explores how plastics associated with IVF laboratory products can be collected and recycled, reflecting commitment to sustainability in healthcare environments.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-04
Description

CooperSurgical partnered with Transmutation as recycling partner for the sustainART pilot program. First materials delivered to Transmutation's recycling facility for processing of IVF laboratory plastics.

3Complementary Reproductive Health Supplement Distribution Assets
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-03-01
Description

CooperSurgical (via CooperSurgical) acquired complementary reproductive health supplement distribution assets in the U.S. in March 2025, expanding its presence in the fertility supplements market.

openpr.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

CooperCompanies acquired obp Surgical, a U.S.-based medical device company, for approximately $100 million. The acquisition expands CooperSurgical's surgical portfolio with products including surgical retractors and suction devices. Products generating $14.5 million in revenue included in Office and Surgical category beginning Q4 2024.

5ZyMōt Fertility (DxNow, Inc.)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-06-10
Description

CooperSurgical acquired ZyMōt Fertility, a subsidiary of DxNow, Inc., adding a first-of-its-kind sperm separation device to its portfolio. ZyMōt's global presence commercializing patented sperm separation technology strengthens CooperSurgical's leadership in fertility solutions. The device uses a patented approach to separate motile sperm from non-motile sperm for improved IVF outcomes.

coopersurgical.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-05-03
Description

CooperCompanies acquired obp Medical Corporation for approximately $60 million. The company specialized in single-use illuminated vaginal speculums and other medical devices, enhancing CooperSurgical's women's healthcare offerings. Products generated about $10 million in revenue in trailing twelve months prior to acquisition.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Hologic is a large women's health diagnostics and surgical device company with overlapping products in cervical cancer screening, NovaSure endometrial ablation, and MyoSure tissue removal, addressing the same OB/GYN customer base as CooperSurgical.

TypeDirect peer
Description

Hamilton Thorne provides precision instruments, lasers, and ART laboratory equipment to fertility clinics and reproductive medicine research, overlapping with CooperSurgical's K-Systems workstations, incubators, and micromanipulation products.

TypeDirect peer
Description

FUJIFILM Irvine Scientific manufactures cell culture media and ART consumables used by IVF clinics worldwide, directly competing with CooperSurgical's embryo culture media and micropipette categories.

TypeBroad incumbent
Description

Medtronic operates a large medical device portfolio with adjacent offerings in gynecological surgery, women's pelvic health, and hospital-based consumables that partially overlap with CooperSurgical's surgical franchise.

TypeDirect peer
Description

Vitrolife is a pure-play IVF/ART media, consumables, and equipment supplier with overlapping media brands, time-lapse embryo imaging, and lab solutions that compete head-to-head with CooperSurgical's LifeGlobal, ORIGIO, SAGE, and K-Systems product lines.

TypeDirect peer
Description

Cryo-Cell International operates one of the leading private cord blood and stem cell banking services in the U.S., directly competing with CooperSurgical's Cord Blood Registry (CBR) and California Cryobank family-banking brands.

TypeEmerging player
Description

Genea Biomedx develops IVF lab instrumentation, benchtop incubators, and culture-monitoring devices for assisted reproduction, overlapping with CooperSurgical's K-Systems incubator and workstation offerings in a niche but rapidly growing segment.

TypeBroad incumbent
Description

Merck KGaA supplies ART media, cryopreservation solutions, and fertility medications through its Life Science and Healthcare divisions, overlapping with CooperSurgical's IVF media and consumables portfolio as well as the broader reproductive health medication space (e.g., Granata Bio investment).

TypeDirect peer
Description

Rocket Medical designs and supplies single-use ART devices including embryo transfer catheters, oocyte retrieval needles, and IUI catheters, directly competing with CooperSurgical's Wallace catheter portfolio.

TypeBroad incumbent
Description

Boston Scientific provides a broad portfolio of gynecological surgical devices and pelvic health products addressing the same gynecological surgeons and hospitals that CooperSurgical serves with its RUMI II, Lone Star, and ALLY platforms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A20 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CooperSurgical

Women's Health and Fertility Medical Devicescoopersurgical.com

CooperSurgical, a CooperCompanies subsidiary, provides 600+ medical devices and services spanning fertility treatments, ART consumables, labor and delivery, gynecological surgery, and women's health diagnostics to hospitals, fertility clinics, and OB/GYN practices in 130+ countries.

What CooperSurgical does

CooperSurgical, Inc. is a wholly-owned subsidiary of CooperCompanies (Nasdaq: COO) that manufactures and distributes medical devices and consumables for women's health, fertility, and gynecological surgery. Founded in 1990 and headquartered in Trumbull, Connecticut, the company offers more than 600 clinically relevant products organized across reproductive care (Paragard copper IUD, fertility preservation), fertility and birth (ART equipment, media and consumables, donor egg/sperm services, labor and delivery devices), and women's care (office diagnostics, pessaries, gynecological surgical instruments). Operating brands include Paragard, Wallace (catheters used in the first successful IVF), California Cryobank (#1 US sperm bank), Donor Egg Bank USA, Cord Blood Registry, ORIGIO, LifeGlobal, SAGE, K-Systems, RI Witness, ZyMōt, RUMI II, Lone Star, and Fetal Pillow.

The company sells through a global direct sales force serving fertility clinics, hospitals, labor and delivery units, OB/GYN practices, and ambulatory surgery centers, with products registered in over 130 countries and manufacturing operations in the United States, Costa Rica, and Europe. The technology base spans patented IVF laboratory equipment (RI Witness electronic witnessing, K-Systems workstations and incubators, ZyMōt sperm separation), branded ART culture media (LifeGlobal one-step, ORIGIO sequential, SAGE vitrification), labor and delivery disposables (Fetal Pillow, Bakri balloon, DuoRipe, MityOne), and gynecologic surgical instruments (RUMI II uterine manipulator, Lone Star retractor, Advincula Delineator). Pricing is negotiated B2B under multi-year contracts; the company does not publish list prices.

Revenue is generated across four streams: medical device and equipment sales, ART media and consumables, fertility and cryopreservation services (IVF shipping via Core Cryolab, cryo-storage billing via Embryo Options, genetic testing), and donor egg/sperm banking. Growth has been driven by a sustained acquisition program (obp Medical 2021, Cook Medical Reproductive Health 2022, ZyMōt 2024, obp Surgical 2024 at $100M, reproductive supplement distribution 2025) and incremental product launches including an AI-integrated PGT analysis system and the ViaBL warming kit. The parent reported 8% year-over-year revenue growth for the CooperSurgical business unit in Q2 2026. The company also faces ongoing product liability exposure, notably the Paragard multidistrict litigation (over 3,500 cases alleging breakage during removal) and IVF culture media litigation tied to a December 2023 Class 2 recall.

CooperSurgical firmographics

Firmographics
Name
CooperSurgical
Legal name
CooperSurgical, Inc.
Website
https://coopersurgical.com
Company type
Private
Founded year
1990
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
CooperSurgical, a CooperCompanies subsidiary, provides 600+ medical devices and services spanning fertility treatments, ART consumables, labor and delivery, gynecological surgery, and women's health diagnostics to hospitals, fertility clinics, and OB/GYN practices in 130+ countries.
Ownership category
akta.pro rank

CooperSurgical industry classification

Industry
Product category
Women's Health and Fertility Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)
akta.pro secondary industries
Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests) (CRADAMAH)

Keywords

  • Fertility medical devices
  • Women's health products
  • Assisted reproductive technology
  • IVF laboratory equipment
  • Gynecological surgical instruments

Where CooperSurgical is headquartered

Location

Headquarters

HQ city
Trumbull
HQ country
United States
HQ region
North America

Offices29 records

Markets served

CooperSurgical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of medical devices, equipment, and surgical instruments to healthcare providers including fertility clinics, hospitals, and OB/GYN practices. Products include ART equipment, surgical instruments, diagnostic devices, and fertility consumables.
  2. ART Media and Consumables: Sale of assisted reproductive technology media, culture solutions, and consumables for IVF laboratories including dishes, pipettes, needles, catheters, and vitrification products.
  3. Services: Services including IVF shipping (Core Cryolab), cryo-storage billing (Embryo Options), fertility preservation, and genetic testing services.
  4. Donor Egg and Sperm: Sale of donor sperm and eggs through California Cryobank and Donor Egg Bank USA, including newborn stem cell banking through Cord Blood Registry.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractNo public tiered pricing available

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

CooperSurgical product offering

Product offering

Core offering

CooperSurgical manufactures and sells a portfolio of over 600 clinically relevant medical devices and consumables for women's healthcare providers, spanning contraception (Paragard IUD), assisted reproductive technology (IVF equipment, media, consumables), labor and delivery products, gynecological surgical instruments, and women's health diagnostics. The company also provides related services including IVF shipping, cryo-storage billing, donor egg and sperm banking, and newborn stem cell preservation through sub-brands such as California Cryobank, Donor Egg Bank USA, and Cord Blood Registry.

Product overview

CooperSurgical offers a comprehensive portfolio of over 600 clinically relevant medical devices for women's healthcare providers, encompassing fertility and birth solutions, reproductive care, and women's health. The product portfolio operates as a multi-brand platform organized across three main categories: Reproductive Care (Paragard copper IUD, fertility preservation), Fertility & Birth (ART equipment, media, consumables, genetic testing, donor services, labor & delivery), and Women's & Family Care (surgical instruments, diagnostics, pessaries). Key brands include LifeGlobal, ORIGIO, and SAGE for embryo culture media; K-Systems for IVF workstations; Wallace and RI Witness for ART procedures; California Cryobank and Cord Blood Registry for family banking; plus surgical brands like RUMI II, Lone Star, and ALLY II UPS for gynecological surgery. The portfolio spans from contraception to fertility treatments, labor and delivery, and surgical interventions.

Differentiator

Problem solved

Functional benefit

Brands

  • Paragard: Intrauterine copper contraceptive for pregnancy prevention for up to 10 years
  • California Cryobank
  • Donor Egg Bank USA
  • Core Cryolab
  • Embryo Options
  • K-Systems
  • LifeGlobal
  • ORIGIO
  • SAGE
  • Wallace
  • Cord Blood Registry (CBR)
  • Fetal Pillow
  • INSORB
  • Bakri
  • Endosee
  • Milex
  • RUMI II
  • Lone Star
  • ALLY II UPS
  • ONETRAC LX
  • ER-Complete
  • PGT-Complete
  • RI Witness
  • ZyMōt

Products and services

  • Paragard Copper IUD Copper-containing intrauterine system (IUS) indicated for prevention of pregnancy for up to 10 years. Provides proven >99% efficacy, 100% hormone-free contraception that is immediately reversible. Sold to healthcare providers including OB/GYN practices.
  • ZyMōt Multi Sperm Separation Device Sperm separation device using a patented approach to separate motile sperm from non-motile sperm in a semen sample. Motile sperm separated by the device are more likely to help patients achieve a successful pregnancy. Sold to fertility clinics and ART laboratories.
  • California Cryobank The #1 sperm bank in the U.S. offering one of the world's largest and most diverse donor catalogs with rigorous donor screening requirements, financing, and storage options. Provides donor sperm for fertility clinics and patients.
  • Donor Egg Bank USA Expert in egg vitrification, providing access to donor egg services with comprehensive screening and storage options. Recognized as #1 egg bank in the U.S.
  • Cord Blood Registry (CBR) #1 recommended newborn stem cell preservation company by OB/GYNs, helping families preserve stem cells from cord blood for future medical use.
  • Embryo Options Digital cryopreservation billing and management platform that automates cryo-storage billing, enables real-time account access, and provides embryo disposition options including donation to research, donation to another family, or thaw and discard.
  • Core Cryolab IVF Shipping IVF shipping solutions providing transport of cryopreserved materials for clinics and patients since 2005.
  • LifeGlobal Media Pioneer and leader in 1-Step media for embryo culture, offering high-quality pharmaceutical-grade mineral oils and HSA for ART applications.
  • ORIGIO Sequential Series Media Innovative IVF media positioned as one of the leaders in the global IVF Media market, offering sequential series media and micropipettes for embryo culture.
  • SAGE Vitrification Solutions Vitrification solutions including SAGE 1-Step culture and transfer medium, GM-CSF variants, and ViaBL warming kits.
  • K-Systems Workstations and Incubators Range of workstations, incubators, and supporting equipment designed for IVF laboratories.
  • Wallace Catheters Wallace catheter was used in the first successful IVF treatment and remains the most popular catheter worldwide. Includes oocyte recovery systems, IUI catheters, and embryo transfer catheters.
  • RI Witness Electronic Witnessing System Electronic witnessing system that constantly communicates with patient management systems to prevent sample misidentification in IVF laboratories.
  • PGT-Complete Genetic Test Four-in-one genetic test for preimplantation genetic testing, providing clinically comprehensive insights for embryo selection.
  • ER-Complete Test 3-in-1 test for optimal endometrium and embryo transfer, identifying the right time and right environment for embryo transfer.
  • Endosee Advance System Office hysteroscopy device incorporating benefits of direct visualization without limitations of traditional hysteroscopy for office-based procedures in OB/GYN practices.
  • Milex Pessaries Pessaries for pelvic organ prolapse and urinary incontinence including ring, Gellhorn, cube, Gehrung, Shaatz pessaries and vaginal dilators.
  • RUMI II Uterine Manipulator Uterine manipulation devices with articulating system, locking handle, soft distal tip, silicone balloon, and integrated catheter for chromopertubation for gynecologic laparoscopic procedures.
  • Lone Star Self-Retaining Retractor System Self-retaining retractor system providing incision retraction and aiding visualization during surgical procedures, including disposable elastic stays and rings.
  • ALLY II UPS Uterine Positioning System Uterine positioning system designed for minimally invasive gynecological procedures with redesigned stability and improved mobility.
  • Advincula Delineator Single-use disposable uterine manipulator designed for TLH, LSH, and LAVH procedures with Koh-Efficient system integrated and rigid colpotomy cup.
  • ONETRAC LX Surgical Retractor Single-use, cordless surgical retractor with integrated multi-LED light source for specialty surgery procedures.
  • INSORB Skin Stapler Absorbable skin stapler providing rapid, cosmesis-proven skin closure solution for C-section and other surgical procedures.
  • Doppler Blood Flow Monitor Provides audible and visual feedback of blood flow during surgical procedures.
  • Bakri Postpartum Balloon Provides temporary control or reduction of postpartum uterine bleeding when conservative management is warranted.
  • Fetal Pillow Cephalic Elevation Device Effective solution for delivering a deeply impacted fetal head during C-section, providing cephalic elevation. FDA 510(k) cleared.
  • DuoRipe Cervical Ripening Balloon Double-balloon catheter for mechanical dilation of cervical canal prior to labor induction at term when cervix is unfavorable.
  • MityOne Vacuum-Assisted Delivery Device One-piece vacuum-assisted delivery device to assist practitioners in delivery of an infant during vacuum-assisted deliveries.
  • Guardian Vaginal Retractor Single-use device designed to achieve improved visualization and access required during vaginal and/or perineal wound repair.
  • Carter-Thomason CloseSure System Single-case use, handheld suture grasping device for port site closure during laparoscopic procedures.
  • See Clear Smoke Evacuation System Passive, disposable, multistage laparoscopic filter system that traps smoke and aerosols during surgical procedures.
  • TPC Micropipettes Range of ICSI, Holding, Biopsy, and Hatching and Dissection micropipettes for IVF laboratory procedures.
  • Quinn's Advantage Sequential Media Sequential media system available in Europe, U.S.A., China and Australia for embryo culture.
  • OB/Mobius Cesarean Section Retractor Elastic retractor providing 360° of circumferential retraction while lining the wound to protect against contamination during C-section.
  • Belly Bands Abdominal Fetal Monitoring Belt Abdominal fetal monitoring belt used to hold transducers in place during fetal monitoring.
  • ViaBL Super-Fast Blastocyst Warming Kit Super-fast blastocyst warming kit launched in March 2025 for IVF procedures, available for sale in select countries worldwide.

Quantifiable outcome

  • 8% year-over-year revenue growth in CooperSurgical business unit (Q2 2026)
  • +2 more outcomes

Companies that use CooperSurgical

Customer profile

Named customers4 records

Segments6 records

Ideal customer profiles4 records

CooperSurgical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

CooperSurgical partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • Adora FertilityminorStrategic or Co-development Partner · 4 May 2026CooperSurgical launched sustainART pilot program in Melbourne, Australia with Adora Fertility as the first participating clinic. The program explores how plastics associated with IVF laboratory products can be collected and recycled, reflecting commitment to sustainability in healthcare environments.
  • TransmutationminorStrategic or Co-development Partner · 4 May 2026CooperSurgical partnered with Transmutation as recycling partner for the sustainART pilot program. First materials delivered to Transmutation's recycling facility for processing of IVF laboratory plastics.
  • Complementary Reproductive Health Supplement Distribution AssetsminorStrategic or Co-development Partner · 1 March 2025CooperSurgical (via CooperSurgical) acquired complementary reproductive health supplement distribution assets in the U.S. in March 2025, expanding its presence in the fertility supplements market.
  • obp SurgicalcoreStrategic or Co-development Partner · 1 August 2024CooperCompanies acquired obp Surgical, a U.S.-based medical device company, for approximately $100 million. The acquisition expands CooperSurgical's surgical portfolio with products including surgical retractors and suction devices. Products generating $14.5 million in revenue included in Office and Surgical category beginning Q4 2024.
  • ZyMōt Fertility (DxNow, Inc.)coreStrategic or Co-development Partner · 10 June 2024CooperSurgical acquired ZyMōt Fertility, a subsidiary of DxNow, Inc., adding a first-of-its-kind sperm separation device to its portfolio. ZyMōt's global presence commercializing patented sperm separation technology strengthens CooperSurgical's leadership in fertility solutions. The device uses a patented approach to separate motile sperm from non-motile sperm for improved IVF outcomes.
  • obp Medical CorporationcoreStrategic or Co-development Partner · 3 May 2021CooperCompanies acquired obp Medical Corporation for approximately $60 million. The company specialized in single-use illuminated vaginal speculums and other medical devices, enhancing CooperSurgical's women's healthcare offerings. Products generated about $10 million in revenue in trailing twelve months prior to acquisition.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

CooperSurgical competitors and assessment

Company assessment

Broad incumbents

  • Hologic: Hologic is a large women's health diagnostics and surgical device company with overlapping products in cervical cancer screening, NovaSure endometrial ablation, and MyoSure tissue removal, addressing the same OB/GYN customer base as CooperSurgical.
  • Medtronic: Medtronic operates a large medical device portfolio with adjacent offerings in gynecological surgery, women's pelvic health, and hospital-based consumables that partially overlap with CooperSurgical's surgical franchise.
  • Merck KGaA (Life Science / Fertility): Merck KGaA supplies ART media, cryopreservation solutions, and fertility medications through its Life Science and Healthcare divisions, overlapping with CooperSurgical's IVF media and consumables portfolio as well as the broader reproductive health medication space (e.g., Granata Bio investment).
  • Boston Scientific: Boston Scientific provides a broad portfolio of gynecological surgical devices and pelvic health products addressing the same gynecological surgeons and hospitals that CooperSurgical serves with its RUMI II, Lone Star, and ALLY platforms.

Direct peers

  • Hamilton Thorne: Hamilton Thorne provides precision instruments, lasers, and ART laboratory equipment to fertility clinics and reproductive medicine research, overlapping with CooperSurgical's K-Systems workstations, incubators, and micromanipulation products.
  • FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific manufactures cell culture media and ART consumables used by IVF clinics worldwide, directly competing with CooperSurgical's embryo culture media and micropipette categories.
  • Vitrolife: Vitrolife is a pure-play IVF/ART media, consumables, and equipment supplier with overlapping media brands, time-lapse embryo imaging, and lab solutions that compete head-to-head with CooperSurgical's LifeGlobal, ORIGIO, SAGE, and K-Systems product lines.
  • Cryo-Cell International: Cryo-Cell International operates one of the leading private cord blood and stem cell banking services in the U.S., directly competing with CooperSurgical's Cord Blood Registry (CBR) and California Cryobank family-banking brands.
  • Rocket Medical: Rocket Medical designs and supplies single-use ART devices including embryo transfer catheters, oocyte retrieval needles, and IUI catheters, directly competing with CooperSurgical's Wallace catheter portfolio.

Emerging players

  • Genea Biomedx: Genea Biomedx develops IVF lab instrumentation, benchtop incubators, and culture-monitoring devices for assisted reproduction, overlapping with CooperSurgical's K-Systems incubator and workstation offerings in a niche but rapidly growing segment.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

CooperSurgical social profiles

Digital presence

CooperSurgical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CooperSurgical leadership team

Management profile

Number of profiles

Profiles8 records

CooperSurgical subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

CooperSurgical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CooperSurgical M&A and investment

M&A and investment

M&A20 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CooperSurgical

What does CooperSurgical do?

CooperSurgical manufactures and sells a portfolio of over 600 clinically relevant medical devices and consumables for women's healthcare providers, spanning contraception (Paragard IUD), assisted reproductive technology (IVF equipment, media, consumables), labor and delivery products, gynecological surgical instruments, and women's health diagnostics. The company also provides related services including IVF shipping, cryo-storage billing, donor egg and sperm banking, and newborn stem cell preservation through sub-brands such as California Cryobank, Donor Egg Bank USA, and Cord Blood Registry.

Is CooperSurgical a public or private company?

CooperSurgical is a private company. It is classified as corporate owned and is currently operating.

When was CooperSurgical founded?

CooperSurgical was founded in 1990. It employs 1,001 to 5,000 people.

Where is CooperSurgical based?

CooperSurgical is headquartered in Trumbull, United States, in the North America region.

How does CooperSurgical make money?

Four revenue lines are on record. Medical Device Sales are the primary driver. The others are ART Media and Consumables, services and donor Egg and Sperm.

Who are CooperSurgical's main competitors?

Broad incumbents on record are Hologic, Medtronic, Merck KGaA (Life Science / Fertility) and Boston Scientific. Direct peers are Hamilton Thorne, FUJIFILM Irvine Scientific, Vitrolife, Cryo-Cell International and Rocket Medical. Genea Biomedx is listed as an emerging player.

Does CooperSurgical have an API?

No public API is recorded for CooperSurgical.

What industry is CooperSurgical in?

CooperSurgical's product category is Women's Health and Fertility Medical Devices. Its primary akta.pro industry code is HLAHADAM, Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits), with a secondary code of HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AInvestCooperCompanies: the selloff has outrun the business, but the CooperSurgical exit is the unlockCooperVision reported record Q2 revenue of $1.08 billion, up 8% year over year, while CooperSurgical's litigation charge of $271.6 million pre-tax turned the quarter into a GAAP loss. Management is advancing discussions to sell CooperSurgical, which would unlock a higher multiple for the contact-lens business. The stock's discount is driven by the pending sale, not the lens segment's performance.The Motley FoolWhy is CooperCompanies Stock Down 15% Today?Cooper Companies shares fell 13.9% on Sept. 10 after Q3 earnings missed on sales and weak Q4 guidance. The company reported $1.07B in sales and a Q4 EPS forecast of $1.05-$1.09, below the $1.19 estimate. It also decided not to sell CooperSurgical, removing a potential deal catalyst.The Motley FoolWhy is CooperCompanies Stock Down 15% Today?Cooper Companies shares fell 13.9% on Sept. 10, 2026, after Q3 earnings missed on top-line sales and Q4 guidance of $1.05–$1.09 per share beat below Wall Street's $1.19 estimate. The company also decided not to sell CooperSurgical, removing a deal catalyst, while lower inventory at contact-lens distributors pressures vision business earnings.AInvestCooperCompanies: Keeping CooperSurgical Was the Easy Part — the Flagship's Stall Is the Real TestCooperCompanies retained CooperSurgical after its strategic review, but shares fell 6% as growth concerns over its contact lens business intensified. CooperVision's revenue was flat, and its organic growth guidance was cut to 1-2% for fiscal 2026. The stock's valuation depends on whether the stall is temporary or reflects lasting market share loss.Quiver QuantitativeCooperCompanies Slides as Reduced Outlook and CooperSurgical Decision Weigh on Shares | COO Stock NewsCooperCompanies shares fell 19.3% after fiscal Q3 results showed a weaker-than-expected outlook and the company chose to keep CooperSurgical rather than sell it. The decision overshadowed an EPS beat and expanded buyback plan. Analysts' median price target is $85.Investing.comCooper Companies tumbles on weak guidance, strategic review conclusion By Investing.comCooperCompanies shares plunged 15% in after-hours trading after the medical device company reported third-quarter results that missed revenue expectations and issued fourth-quarter and full-year guidance significantly below analyst estimates. The company reported adjusted earnings per share of $1.15 for the fiscal third quarter, beating consensus, but announced it would retain CooperSurgical following a strategic review. For the fourth quarter, adjusted EPS is expected between $1.05 and $1.09, well below the $1.19 consensus, while full-year EPS guidance of $4.51 to $4.55 also trails expectations.Investing.comCooperCompanies retains CooperSurgical, expands buyback to $3B By Investing.comCooperCompanies retained its CooperSurgical business unit after a strategic review, deciding against a sale. The company expanded its share repurchase authorization to $3 billion and added two independent directors. It plans to open The Vision Centre R&D hub on September 23, 2026.EIN PresswireIn-Vitro Fertilization Market to reach USD 55.94 Billion by 2035 at 7.70% CAGRThe global IVF market is projected to grow from USD 26.65 billion in 2025 to USD 55.94 billion by 2035, a 7.70% CAGR. Growth is driven by rising infertility prevalence, employer benefit expansion, and lab automation. North America leads with 38.5% of global revenue in 2025.Lawsuit Information CenterParagard IUD Lawsuit Settlement AmountsOver 4,000 federal lawsuits are pending against Teva and CooperSurgical regarding the Paragard IUD after allegations that the device fractures during removal. The first bellwether trial ended in a defense verdict for the defendants in February 2026, while the next trial is scheduled for September 2026 to further evaluate claims of design defects and failure to warn. No global settlement has been reached yet, with estimates suggesting potential payouts ranging from $5,000 to over $380,000 depending on injury severity.Business Wire BlogCooperSurgical Supports Saving Mothers to Help Advance Global Women’s Health and Raise AwarenessCooperSurgical, a global leader in women's health and fertility, announced its sponsorship and support for Saving Mothers, a nonprofit organization dedicated to reducing maternal morbidity and mortality worldwide through innovative, scalable solutions. The collaboration will support Saving Mothers' educational initiatives, including the 'Health Starts with Her' YouTube talk show, and coincides with Fibroid Awareness Month in July to highlight conditions like fibroids and endometriosis that affect millions of women globally. Saving Mothers, founded by Dr. Taraneh Shirazian, works to empower women in resource-limited settings by training local medical providers and bringing lifesaving medical technologies to underserved areas.